Abstract CN11
Background
Patients with prostate cancer may experience a worsening in their emotional wellbeing and physical health due to treatments or disease burden. It has been reported that physical activity and lifestyle interventions are associated with improved patient outcomes and a lack of health literacy is perceived by patients as a key burden of their cancer experience, and an improvement in this aspect has been strongly correlated with better overall survival. Voice assistants have emerged as a promising tool to support patients' guided learning and exercises. Here, we report on the development, content, and functionality of the first Amazon Alexa voice assistant for patients living with prostate cancer in Spain.
Methods
A multidisciplinary group of expert physicians on prostate cancer were selected as a scientific committee. Based on their clinical experience and the scientific evidence, the working group agreed on and created the content. The topics for each module were defined through the use of a consensus technique. The digital skill, named ProstaGYM, was endorsed by the national patient association ANCAP and the design and programming was performed by an Amazon developer with support from Bayer Hispania.
Results
The skill contains four content modules: 1) general disease information and healthy lifestyle recommendations, 2) exercise routines to prevent sarcopenia, 3) specific exercises and interventions to manage urinary symptoms, 4) advice on sexual health and psychological support. ProstaGYM is available free of charge on the Spain Amazon Alexa skill store. Since its launch in November 2022, the following information on metrics were obtained (cut-off 30th April 2023): 144 unique customers, 164 user enablements (skill activation) and 182 sessions.
Conclusions
The skill ProstaGYM constitutes an innovative approach to guide patients with prostate cancer to self-manage disease symptoms and treatment side effects and promote physical exercise that may improve their quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Bayer Hispania.
Funding
Bayer Hispania.
Disclosure
E. Gallardo: Financial Interests, Institutional, Speaker, Consultant, Advisor, Grant support, Travel/accomodation expenses: Sanofi, Janssen, Astellas, Bayer, Ipsen, Pfizer, Roche, Bristol Myers Squibb; Financial Interests, Institutional, Speaker, Consultant, Advisor: Novartis, EUSA Pharma, MSD, Merck, Rovi, Daiichi Sankyo, Techdow, Lilly, Advanced Accelerator Applications; Financial Interests, Institutional, Speaker, Consultant, Advisor, Travel/Accomodation expenses: Eisai, AstraZeneca; Financial Interests, Institutional, Research Grant, Grant support: Ferrer; Financial Interests, Institutional, Other, Travel/Accomodation expenses: Pierre Fabre. D. Büchser Garcia: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Astellas, Janssen. L. Regis Placido: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Recordati. E. Rios Gonzalez: Financial Interests, Institutional, Speaker, Consultant, Advisor: Bayer, Janssen, Recordati, Merck, AstraZeneca; Financial Interests, Institutional, Speaker’s Bureau: Astellas. A. Marco Perez, C. Moretones Agut: Non-Financial Interests, Institutional, Other, Employee: Bayer.
Resources from the same session
CN75 - Validation of a symptom diary for outpatients with cancer receiving intravenous chemotherapy and/or targeted therapy
Presenter: José Koldenhof
Session: Poster session 25
Resources:
Abstract
CN86 - Advanced breast cancer care for nurses (ABC4Nurses): A mixed-methods evaluation of an online educational programme
Presenter: Sarah Sheehan
Session: Poster session 25
Resources:
Abstract
CN87 - An accreditation tool towards safe quality cancer nursing care
Presenter: Fernanda Conceição
Session: Poster session 25
Resources:
Abstract
CN88 - Handling cancer drugs: Inventory of the state of knowledge and educational opportunities in Sweden
Presenter: Anki Delin Eriksson
Session: Poster session 25
Resources:
Abstract
CN89 - In cancer care nursing, does the use of surface wipe sampling for hazardous drugs lead to a safer occupational environment, in an outpatient and inpatient oncology/haematology setting? An evidence translation proposal
Presenter: Audrey O'Halloran
Session: Poster session 25
Resources:
Abstract
CN90 - Managing the increasing capacity pressures in a nurse-led rural, satellite oncology unit in the era of immunotherapy
Presenter: SANDRA MURPHY
Session: Poster session 25
Resources:
Abstract
CN91 - Mentors' roles and responsibilities expected by nursing students in clinical training at the institute of oncology Ljubljana, Slovenia
Presenter: Miladinka Matković
Session: Poster session 25
Resources:
Abstract
CN92 - Nursing students’ attitude towards care of dying: A cross-sectional study in Italy
Presenter: Mayra Veronese
Session: Poster session 25
Resources:
Abstract
CN93 - Strategic patient collaboration, cancer theme Karolinska comprehensive cancer center (CCC)
Presenter: Ann-Britt Johansson
Session: Poster session 25
Resources:
Abstract
CN94 - The effect of a compassion fatigue resiliency program on oncology-hematology nurses' professional quality of life, stress levels and patients' care satisfaction: Nurse, patient and nurse manager’s perspectives
Presenter: Tugba Pehlivan Sarıbudak
Session: Poster session 25
Resources:
Abstract